Sign in

CIK 0001516551

  • Non-accelerated filer
  • Smaller reporting company

Skye Bioscience, Inc.

Sign in to watch
Ticker
SKYE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
NV
Entity type
Operating
EIN
450692882
Phone
+1 858-410-0266
Business address
11250 EL CAMINO REAL, SUITE 100, SAN DIEGO, CA, 92130
Former names
Emerald Bioscience, Inc., Nemus Bioscience, Inc., LOAD GUARD LOGISTICS, INC., LOAD GUARD TRANSPORTATION, INC.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$613,506
in 6 filings

Net −$613,506. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-03-31 Diep Tuan Tu Chief Operating Officer Grant or award · Stock Option (Right to Buy) +75,000 75,000
2026-03-31 Diep Tuan Tu Chief Operating Officer Returned to the company · Stock Option (Right to Buy) −75,000 0
2026-03-31 DHILLON PUNIT Chief Executive Officer Grant or award · Stock Option (Right to Buy) +250,000 250,000
2026-03-31 DHILLON PUNIT Chief Executive Officer Returned to the company · Stock Option (Right to Buy) −250,000 0
2026-03-31 DHILLON PUNIT Chief Executive Officer Grant or award · Stock Option (Right to Buy) +36,000 36,000
2026-03-31 DHILLON PUNIT Chief Executive Officer Returned to the company · Stock Option (Right to Buy) −36,000 0
2026-03-31 DHILLON PUNIT Chief Executive Officer Grant or award · Stock Option (Right to Buy) +12,360 12,360
2026-03-31 DHILLON PUNIT Chief Executive Officer Returned to the company · Stock Option (Right to Buy) −12,360 0
2026-03-31 DHILLON PUNIT Chief Executive Officer Grant or award · Stock Option (Right to Buy) +650,000 650,000
2026-03-31 DHILLON PUNIT Chief Executive Officer Returned to the company · Stock Option (Right to Buy) −650,000 0
2026-03-31 DHILLON PUNIT Chief Executive Officer Grant or award · Stock Option (Right to Buy) +125,000 125,000
2026-03-31 DHILLON PUNIT Chief Executive Officer Returned to the company · Stock Option (Right to Buy) −125,000 0
2026-03-31 DHILLON PUNIT Chief Executive Officer Grant or award · Stock Option (Right to Buy) +9,013 9,013
2026-03-31 DHILLON PUNIT Chief Executive Officer Returned to the company · Stock Option (Right to Buy) −9,013 0
2026-03-31 DHILLON PUNIT Chief Executive Officer Grant or award · Stock Option (Right to Buy) +21,586 21,586
2026-03-31 DHILLON PUNIT Chief Executive Officer Returned to the company · Stock Option (Right to Buy) −21,586 0
2026-02-06 Schwab Andrew J. Director Grant or award · Stock Option (Right to Buy) +35,000 35,000
2026-02-06 Grayson Paul A. Director Grant or award · Stock Option (Right to Buy) +35,000 35,000
2026-02-06 Smith Karen L. Director Grant or award · Stock Option (Right to Buy) +35,000 35,000
2026-02-06 ARSENAULT KAITLYN Chief Financial Officer Grant or award · Stock Option (Right to Buy) +125,000 125,000

Page 4 of 15 · 292 trades